收藏切换
Clinical progress of glucagon-like peptide-1 receptor agonists in the treatment of metabolically associated steatohepatitis
收藏切换
Yanyan ZENG1, Zhilong LAN2, Yingbo LI2, Shan JIANG2, Na NI1, *, Junlong WANG1, *
World Clinical Drug | 2025, 46(2) : 130 - 137
Less
收藏切换
World Clinical Drug | 2025, 46(2): 130-137
• Topic •
Clinical progress of glucagon-like peptide-1 receptor agonists in the treatment of metabolically associated steatohepatitis
Full
Yanyan ZENG1, Zhilong LAN2, Yingbo LI2, Shan JIANG2, Na NI1, *, Junlong WANG1, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China
Published: 2025-02-10 doi: 10.13683/j.wph.2025.02.003
Outline
收藏切换

Metabolic associated steatohepatitis(MASH), formerly known as non-alcoholic steatohepatitis. If the disease is not controlled, it can lead to cirrhosis and liver cancer. With the continuous development of the discipline, the diagnosis and treatment of MASH have made great progress. However, because of its complex mechanism of action, many clinical trials have failed even after entering phase Ⅲ. This aritcle focused on the metabolic disorder of MASH, and summarized the double/triple receptor agonists targeting the metabolism of glucagon peptide-1 receptor and other incretin signaling pathways, so as to provide certain references for the better development of MASH treatment and the design of related clinical trials.

glucagon-like peptide-1  /  glucagon-like peptide-1 receptor agonists  /  metabolic associated steatohepatitis  /  non-alcoholic steatohepatitis  /  metabolic associated fatty liver disease  /  non-alcoholic fatty liver disease
曾艳艳, 兰志龙, 李英博, 姜山, 倪娜, 王俊龙. 胰高血糖素样肽-1受体激动剂治疗代谢相关脂肪性肝炎的临床研究进展. 世界临床药物, 2025 , 46 (2) : 130 -137 . DOI: 10.13683/j.wph.2025.02.003
Yanyan ZENG, Zhilong LAN, Yingbo LI, Shan JIANG, Na NI, Junlong WANG. Clinical progress of glucagon-like peptide-1 receptor agonists in the treatment of metabolically associated steatohepatitis[J]. World Clinical Drug, 2025 , 46 (2) : 130 -137 . DOI: 10.13683/j.wph.2025.02.003
Year 2025 volume 46 Issue 2
56
12
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.02.003
  • Receive Date:2024-12-17
  • Online Date:2026-11-09
  • Published:2025-02-10
Article Data
Affiliations
History
  • Received:2024-12-17
Affiliations
    1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai InnoClinic Pharmaceutical Development Co, Ltd., Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.02.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT